Implementing Quality by Design from Day Minus One: Leveraging Raw Material Qualification & Analytical Assays to de-risk Cell Therapy Manufacturing
2:10 pm - Tuesday 27th October 2026
- When CMC gaps become regulatory events: business cases
- Quality by design from day minus one: why raw materials should be treated as process design parameters from the start
- Analytics as the bridge between material and product quality
